Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
galantamine
|
| gptkbp:approvalYear |
2001
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
N06DA04
|
| gptkbp:brand |
galantamine
|
| gptkbp:contraindication |
severe renal impairment
severe hepatic impairment |
| gptkbp:drugClass |
gptkb:acetylcholinesterase_inhibitor
|
| https://www.w3.org/2000/01/rdf-schema#label |
Reminyl
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Janssen_Pharmaceuticals
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
vomiting diarrhea anorexia dizziness |
| gptkbp:usedFor |
gptkb:Alzheimer's_disease
|
| gptkbp:bfsParent |
gptkb:Janssen_Pharmaceuticals
|
| gptkbp:bfsLayer |
5
|